Skip to search formSkip to main contentSkip to account menu

Granisetron Hydrochloride

Known as: Granisetron Monohydrochloride, Endo-N-(9-methyl-9-azabicyclo [3.3.1] non-3-yl)-1-methyl-1H-indazole-3-carboxamide Hydrochloride, Granisetron Hydrochloride [Chemical/Ingredient] 
The hydrochloride salt of an indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The objective of this study was to develop an oral transmucosal formulation of an antiemetic drug that can not only serve in the… 
2010
2010
The objective of this study was to develop and evaluate nanoemulsion system for transdermal delivery of granisetron hydrochloride… 
2008
2008
BACKGROUND AND OBJECTIVES: It is calculated that the incidence of postoperative nausea and vomiting (PONV) is approximately 30… 
2005
2005
PurposeThe purpose of this work was to demonstrate the iontophoretic delivery of granisetron hydrochloride by novel, self… 
1999
1999
The semisynthetic derivative of camptothecin, irinotecan (CPT-11), has been used extensively as second-line chemotherapy for… 
1998
1998
Background: Breast surgery is associated with a relatively high incidence of postoperative nausea and vomiting (PONV). This study… 
1994
1994
The effect of Y-25130 on gastric emptying of nutrient test meals (solid chow) was examined in mice. In a dose range of 0.01-1 mg…